Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation

References

• Shapiro SD, Reilly JJJ, Rennard SI. Chronic bronchitis and emphysema. In: RJ Mason VCB, TR Martin, TE King Jr., DE Schraufnagel, JF Murray, JA Nadel, editors. Textbook of Respiratory Medicine, 5th ed. Philadelphia: Saunders, 2010; 919–967.
   Google Scholar
• Centers for disease control and prevention. Atlanta, Ga. National health interview survey. www.cdc.gov/nchs/nhis.htm
   Google Scholar
• Centers for Disease Control and Prevention. Atlanta, Ga. Behavioral risk factor surveillance system: survey data and documentation. http://www.cdc.gov/brfss/technical-infodata.htm
   Google Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. Chronic obstructive pulmonary disease surveillance-united states, 1999–2011. Chest 2013; in press.
   Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51:1–16.
   PubMed Web of Science ®Google Scholar
• Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW. Undertreatment of copd: A retrospective analysis of us managed care and medicare patients. Int J Chron Obstruct Pulmon Dis 2012; 7:1–9.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Ichinose M, Inoue H, Shirato K, Hattori T, Takishima T. Underdiagnosis and undertreatment of copd in primary care settings. Respirology 2003; 8:504–508.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The national emphysema treatment trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med 2011; 184:763–770.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung and Blood Institute, Bethesda MD. COPD: Learn more breathe better. 2013. www.nhlbi.nih.gov/health/public/lung/copd/index.htm
   Google Scholar
• Petty TL, Doherty DE. The National Lung Health Education Program: Roots, mission, future directions. Respir Care 2004; 49:678–683.
   PubMedGoogle Scholar
• COPDFoundation. Drive4copd. 2013.
   Google Scholar
• Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res Pol Syst/BioMed Cent 2006;4:27.
   PubMedGoogle Scholar
• Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 5. Group processes. Health Res Pol Syst/BioMed Centr 2006; 4:17.
   PubMedGoogle Scholar
• Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Pol Syst/BioMed Centr 2006; 4:15.
   PubMedGoogle Scholar
• Oxman AD, Fretheim A, Schunemann HJ. Improving the use of research evidence in guideline development: Introduction. Health Res Pol Syst/BioMed Central 2006; 4:12.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 16. Evaluation. Health Res Pol Syst/BioMed Cent 2006; 4:28.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 14. Reporting guidelines. Health Res Pol Syst/BioMed Cent 2006; 4:26.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity. Health Res Pol Syst/BioMed Cent 2006; 4:24.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. Health Res Pol Syst/ BioMed Central 2006; 4:20.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 7. Deciding what evidence to include. Health Res Pol Syst/BioMed Central 2006; 4:19.
   PubMedGoogle Scholar
• Oxman AD, Schunemann HJ, Fretheim A. Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Pol Syst/BioMed Cent 2006; 4:14.
   PubMedGoogle Scholar
• Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Pol Syst/BioMed Cent 2006; 4:25.
   PubMedGoogle Scholar
• Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Pol Systems/BioMed Cent 2006; 4:22.
   PubMedGoogle Scholar
• Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Pol Syst/BioMed Cent 2006; 4:21.
   PubMedGoogle Scholar
• Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Pol Syst/BioMed Central 2006; 4:13.
   PubMedGoogle Scholar
• Schunemann HJ, Oxman AD, Fretheim A. Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Pol Syst/BioMed Centr 2006; 4:18.
   PubMedGoogle Scholar
• Boyd EA, Bero LA. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health Res Pol Syst/BioMed Centr 2006; 4:16.
   PubMedGoogle Scholar
• Edejer TT. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications. Health Res Pol Syst/BioMed Centr 2006; 4:23.
   PubMedGoogle Scholar
• http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
   Google Scholar
• Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347–365.
   PubMed Web of Science ®Google Scholar
• http://www.ers-education.org/pages/default.aspx?id=2005.
   Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with copd: A summary of the ats/ers position paper. Eur Respir J 2004;23:932-946.
   PubMed Web of Science ®Google Scholar
• http://www.nice.org.uk/nicemedia/live/13029/49425/49425.pdf.
   Google Scholar
• Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schunemann H, Wedzicha W, MacDonald R, Shekelle P. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155:179–191.
   PubMed Web of Science ®Google Scholar
• Wilson KC, Irwin RS, File TM, Jr., Schunemann HJ, Guyatt GH, Rabe KF. Reporting and publishing guidelines: Article 12 in integrating and coordinating efforts in copd guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 2012; 9:293–297.
   PubMedGoogle Scholar
• http://www.nice.org.uk/nicemedia/live/13029/49399/49399.pdf.
   Google Scholar
• McIvor RA, Chapman KR. The coming of age of asthma guidelines. Lancet 2008; 372:1021–1022.
   PubMed Web of Science ®Google Scholar
• National Heart, Lung and Blood Institute, Rockville, MD. NHLBI workshop: A case-finding strategy for moderate-to-severe COPD in the United States. 2008. http://www.nhlbi.nih.gov/meetings/workshops/case-finding-exesum.htm
   Google Scholar
• National Heart, Lung and Blood Institute, Rockville, MD. NHLBI. RFA-hl-12-011: Development and testing of a case finding methodology in COPD. 2011. http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-011.html
   Google Scholar
• Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of copd. Eur Respir J 2008; 31:204–212.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, Leff B, Kent DM, Schunemann HJ. How to integrate multiple comorbidities in guideline development: Article 10 in integrating and coordinating efforts in copd guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 2012; 9:274–281.
   PubMedGoogle Scholar
• Enright PL, Ruppel GL. Don't use the flawed fixed ratio to diagnosis copd. Respir Care 2009; 54:1500; author reply 1500.
   PubMed Web of Science ®Google Scholar
• Guder G, Brenner S, Angermann CE, Ertl G, Held M, Sachs AP, Lammers JW, Zanen P, Hoes AW, Stork S, Rutten FH. GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 2012; 13:13.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest 2012; 141:73–80.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Soriano JB, Miravitlles M, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Overdiagnosing subjects with copd using the 0.7 fixed ratio: Correlation with a poor health-related quality of life. Chest 2011; 139:1072–1080.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Agusti A, Vestbo J. What is COPD anyway? Amer J Resp Crit Care Med (in press).
   Google Scholar
• Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, Crapo JD, Silverman EK. Clinical and radiographic predictors of GOLD-unclassified smokers in the copdgene study. Am J Respir Crit Care Med 2011; 184:57–63.
   PubMed Web of Science ®Google Scholar
• Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1979; 118:1S–120S.
   Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the copd assessment test. Eur Respir J 2009; 34:648–654.
   PubMed Web of Science ®Google Scholar
• Sin DD, Golmohammadi K, Jacobs P. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. Amer J Med 2004; 116:325–331.
   PubMed Web of Science ®Google Scholar
• Anzueto A. Impact of exacerbations on COPD. Euro Respir Rev: J Euro Respir Soc 2010; 19:113–118.
   PubMedGoogle Scholar
• Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363:1128–1138.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359:1543–1554.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775–789.
   PubMed Web of Science ®Google Scholar
• ZuWallach RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001; 119:1661–1670.
   PubMed Web of Science ®Google Scholar
• Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA, Jr., Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR. Azithromycin for prevention of exacerbations of copd. N Engl J Med 2011; 365:689–698.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Wilkinson TM, Hurst JR, Perera WR, Sapsford RJ, Wedzicha JA. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 178:1139–1147.
   PubMed Web of Science ®Google Scholar
• Cogo R, Ramponi A, Scivoletto G, Rippoli R. Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: A clinical and pharmacoeconomic study. Acta Bio-medica: Atenei Parmensis 2003; 74:81–87.
   PubMedGoogle Scholar
• Rennard SI, Calverley PM, Goehring UM, Bredenbroker D, Martinez FJ. Reduction of exacerbations by the pde4 inhibitor roflumilast—The importance of defining different subsets of patients with COPD. Respir Res 2011; 12:18.
   PubMed Web of Science ®Google Scholar
• Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ. Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trials. Lancet 2009; 374:685–694.
   PubMed Web of Science ®Google Scholar
• Stuart-Harris C, Bishop JM, Clark TJH, Dornhorst AC, Cotes JE, Flenley DC, Howard P, Oldham PD. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681–686.
   PubMed Web of Science ®Google Scholar
• Group NOTT. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial. Nocturnal oxygen therapy trial group. Ann Intern Med 1980; 93:391–398.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services, Baltimore, MD. National coverage determination (NCD) for home use of oxygen (240.2). 1993. http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=169&ncdver=1&NCAId=169&bc=AAAAAAAACAAAAA%3D%3D&
   Google Scholar
• Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: Recommendations for future research: An NHLBI workshop report. Am J Respir Crit Care Med 2006; 174:373–378.
   PubMed Web of Science ®Google Scholar
• Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edula G, Erikkson L, Friedlander A, Galperin-Aizenberg M, Gefter WB, Gierada DS, Grenier PA, Goldin J, Han MK, Hanania NA, Hansel NN, Jacobson FL, Kauczor HU, Kinnula VL, Lipson DA, Lynch DA, MacNee W, Make BJ, Mamary AJ, Mann H, Marchetti N, Mascalchi M, McLennan G, Murphy JR, Naidich D, Nath H, Newell JD, Jr., Pistolesi M, Regan EA, Reilly JJ, Sandhaus R, Schroeder JD, Sciurba F, Shaker S, Sharafkhaneh A, Silverman EK, Steiner RM, Strange C, Sverzellati N, Tashjian JH, van Beek EJ, Washington L, Washko GR, Westney G, Wood SA, Woodruff PG. A combined pulmonary-radiology workshop for visual evaluation of COPD: Study design, chest ct findings and concordance with quantitative evaluation. COPD 2012; 9:151–159.
   PubMedGoogle Scholar
• Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galban S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nature Med 2012; 18:1711–1715.
   PubMed Web of Science ®Google Scholar
• Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059–2073.
   PubMed Web of Science ®Google Scholar
• Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The national emphysema treatment trial (nett) part II: Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011; 184:881–893.
   PubMed Web of Science ®Google Scholar
• Society AT. Chronic bronchitis, asthma and pulmonary emphysema: A statement by the committee on diagnostic standards for nontuberculous respiratory diseases. Am Rev Respir Dis 1962; 85:762–768.
   Web of Science ®Google Scholar
• Holguin F, Folch E, Redd SC, Mannino DM. Comorbidity and mortality in COPD-related hospitalizations in the united states, 1979 to 2001. Chest 2005; 128:2005–2011.
   PubMed Web of Science ®Google Scholar
• Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, Stoller JK, Thomashow BM, Turino GM. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Amer J Med 2009; 122:348–355.
   PubMed Web of Science ®Google Scholar
• Silverman EK, Sandhaus RA. Clinical practice. Alpha1-antitrypsin deficiency. N Engl J Med 2009; 360:2749–2757.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O'Hara P, Owens GR, Scanlon PD, Tashkin DP, Wise RA. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of fev1. JAMA 1994; 272:1497–1505.
   PubMed Web of Science ®Google Scholar
• Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial. Lancet 2001; 357:1571–1575.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of varenicline on smoking cessation in patients with mild to moderate copd: A randomized controlled trial. Chest 2011; 139:591–599.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Rockville, MD. Clinical practice guideline treating tobacco use and dependence: 2008 update. 2008. http://hphc.hrsa.gov/buckets/treatingtobacco.pdf
   Google Scholar
• Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131:4S–42S.
   PubMed Web of Science ®Google Scholar
• Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. American Thoracic Society/European Respiratory Society Statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173:1390–1413.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Becker A, Bowie D, Hernandez P, McIvor A, Rouleau M, Bourbeau J, Graham ID, Logan J, Legare F, Ward TF, Cowie RL, Drouin D, Harris SB, Tamblyn R, Ernst P, Tan WC, Partridge MR, Godard P, Herrerias CT, Wilson JW, Stirling L, Rozitis EB, Garvey N, Lougheed D, Labrecque M, Rea R, Holroyde MC, Fagnan D, Dorval E, Pogany L, Kaplan A, Cicutto L, Allen ML, Moraca S, FitzGerald JM, Borduas F. Implementing practice guidelines: A workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Canadian respiratory journal: journal of the Canadian Thoracic Society 2006; 13 Suppl A:5–47.
   PubMedGoogle Scholar
• Johnston NW, Lambert K, Hussack P, Gerhardsson de Verdier M, Higenbottam T, Lewis J, Newbold P, Jenkins M, Norman GR, Coyle PV, McIvor RA. Detection of copd exacerbations and compliance with patient reported daily symptom diaries using a blackberry-based information system. Chest 2013, in press.
   PubMedGoogle Scholar